Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group
Kitsada Wudhikarn, Tanin Intragumtornchai(Chulalongkorn University), Pannee Praditsuktavorn(Chulabhorn Hospital), Lalita Norasetthada(Chiang Mai University), Somchai Wongkhantee(Khon Kaen University), Nonglak Kanitsap(Thammasat University), Tawatchai Suwanban(Rajavithi Hospital), Pimjai Niparuck(Mahidol University), Nisa Makruasi(Srinakharinwirot University), Weerasak Nawarawong(Chiang Mai University), Udomsak Bunworasate(Chulalongkorn University), Kanchana Chansung(Khon Kaen University), Arnuparp Lekhakula(Prince of Songkla University), Tontanai Numbenjapon(Phramongkutklao Hospital), Supachai Ekwattanakit(Siriraj Hospital), Jakrawadee Julamanee(Prince of Songkla University), Peerapon Wong(Naresuan University), Chittima Sirijerachai(Khon Kaen University), Kannadit Prayongratana(Phramongkutklao Hospital), Archrob Khuhapinant(Siriraj Hospital), Suporn Chuncharunee(Mahidol University)
Cited by 2
Related Papers
Clinical Classification, Screening and Diagnosis for Thalassemia
|Hematology/Oncology Clinics of North America|2018|262
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma – Results of a comprehensive meta-analysis
|Cancer Treatment Reviews|2007|86